Stents recubiertos de fármacos para el tratamiento de lesiones complejas: enfoque sobre las lesiones largas y los pequeños vasos

Gruentzig, 1978, Transluminal dilatation of coronary artery stenosis [letter], Lancet, 1, 263, 10.1016/S0140-6736(78)90500-7 American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2002. Williams, 2006, Outcomes of 6906 Patients Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents. Report of the DEScover Registry, Circulation, 114, 2154, 10.1161/CIRCULATIONAHA.106.667915 Morice, 2002, N Engl J Med, 346, 1773, 10.1056/NEJMoa012843 Colombo, 2003, TAXUS II Study Group Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions, Circulation, 108, 788, 10.1161/01.CIR.0000086926.62288.A6 Moses, 2003, SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med, 349, 1315, 10.1056/NEJMoa035071 Stone, 2004, A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease, N Engl J Med, 350, 221, 10.1056/NEJMoa032441 Rao, 2006, On-versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]), Am J Cardiol, 97, 1478, 10.1016/j.amjcard.2005.11.081 Elezi, 1998, Vessel size and long-term outcome after coronary stent placement, Circulation, 98, 1875, 10.1161/01.CIR.98.18.1875 Schunkert, 1999, Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization, J Am Coll Cardiol, 34, 40, 10.1016/S0735-1097(99)00181-3 Kastrati, 2000, A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease: Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries, Circulation, 102, 2593, 10.1161/01.CIR.102.21.2593 Park, 2000, Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries, Eur Heart J, 21, 1785, 10.1053/euhj.1999.1947 Doucet, 2001, Stent placement to prevent restenosis after angioplasty in small coronary arteries, Circulation, 104, 2029, 10.1161/circ.104.17.2029 Schofer, 2003, Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS), Lancet, 362, 1093, 10.1016/S0140-6736(03)14462-5 Schampaert, 2004, The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS), J Am Coll Cardiol, 43, 1110, 10.1016/j.jacc.2004.01.024 Ardissino, 2004, Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial, JAMA, 292, 2727, 10.1001/jama.292.22.2727 Stone, 2005, Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial, JAMA, 294, 1215, 10.1001/jama.294.10.1215 Sousa JE. SVELTE: Study in Patients with De Novo Coronary Artery Lesions in Small Vessels Treated With the Cypher Stent. EuroPCR 2004, the Paris Course on Revascularization. Moses, 2006, Safety and Efficacy of the 2.25 mm Sirolimus-Eluting BX Velocity™ Stent in the Treatment of Patients with De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial, Am J Cardiol, 98, 1455, 10.1016/j.amjcard.2006.06.047 Hirshfeld, 1991, Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators, J Am Coll Cardiol, 18, 647, 10.1016/0735-1097(91)90783-6 Kastrati, 1999, Influence of lesion length on restenosis after coronary stent placement, Am J Cardiol, 83, 1617, 10.1016/S0002-9149(99)00165-4 Antoniucci, 1998, Restenosis after coronary stenting in current clinical practice, Am Heart J, 135, 510, 10.1016/S0002-8703(98)70329-1 Dawkins, 2005, Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of omplex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice, Circulation, 112, 3306, 10.1161/CIRCULATIONAHA.105.552190 Waugh, 2004, The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions, Am J Cardiovasc Drugs, 4, 257, 10.2165/00129784-200404040-00006 Kelbaek, 2006, The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial, J Am Coll Cardiol, 47, 449, 10.1016/j.jacc.2005.10.045 Tsagalou, 2005, Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery, J Am Coll Cardiol, 45, 1570, 10.1016/j.jacc.2005.01.049 Degertekin, 2004, Very long sirolimus-eluting stent implantation for de novo coronary lesions, Am J Cardiol, 93, 826, 10.1016/j.amjcard.2003.12.018 Chu, 2006, Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention, Catheter Cardiovasc Interv, 67, 595, 10.1002/ccd.20665 Chu, 2006, Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention, Catheter Cardiovasc Interv, 68, 62, 10.1002/ccd.20740 Moses JW. Direct Stenting Using the Sirolimus-Eluting Bx VELOCITY Stent (DIRECT). Presented at American College of Cardiology Annual Scientific Session 2004, New Orleans, LA. Disponible en: http://www.medscape.com/viewarticle/471804. Kereiakes, 2006, Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials, J Am Coll Cardiol, 48, 21, 10.1016/j.jacc.2006.02.058 Lee, 2006, Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions, Am J Cardiol, 98, 918, 10.1016/j.amjcard.2006.05.011 Aoki, 2005, «Full metal jacket» (stented length ≥ 64 mm) using drug-eluting stents for de novo coronary artery lesions, Am Heart J, 150, 994, 10.1016/j.ahj.2005.01.050 Urban, 2006, Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry, Circulation, 113, 1434, 10.1161/CIRCULATIONAHA.104.532242 Abizaid, 2006, Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry), Am J Cardiol, 98, 1028, 10.1016/j.amjcard.2006.05.020 Lasala JM. Novel insight into drug-eluting stent practice: 1-year outcomes for ARRIVE 1, a Prospective, Multicenter US Registry Capturing Consecutive Patients Treated with the TAXUS Paclitaxel-Eluting Stent System. Paper presented at: American Heart Association Scientific Sessions; November 15, 2005; Dallas, Texas. Niemela, 2005, Taxus Express stent usage patterns and clinical outcomes: twelve-month results from the European subset of the Global Milestone-II Registry, J Am Coll Cardiol, 45, 50A Russell, 2006, Off-label use: an industry perspective on expanding use beyond approved indications, J Interven Cardiol, 19, 432, 10.1111/j.1540-8183.2006.00185.x Hausleiter, 2002, Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial, Am J Cardiol, 89, 58, 10.1016/S0002-9149(01)02164-6 Morice, 2006, Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial, JAMA, 295, 895, 10.1001/jama.295.8.895 Kim, 2006, Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease, Circulation, 114, 2148, 10.1161/CIRCULATIONAHA.106.666396 Park, 2006, Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions, Catheter Cardiovasc Interv, 67, 589, 10.1002/ccd.20700 Kim, 2006, Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions, Catheter Cardiovasc Interv, 67, 181, 10.1002/ccd.20586 Rodríguez-Granillo, 2005, One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries, J Invasive Cardiol, 17, 409